CombatDaggers123
Greenlighter
- Joined
- Dec 3, 2021
- Messages
- 3
In 2008 I discovered a new opiate drug cocktail. The cocktail it the equipotent administration of major morphine metabolite (morphine or heroin) and oxycodone.
The pharmokinetics are simple but sound.
The morphine metabolite stimulates the Mu opiate receptor. The oxycodone stimulates the Kappa opiate receptor. The stimulation of the two receptors at the same time causes an interaction.
In 2009 we tested this new cocktail on some opiate addicts at a heroin maintenance clinic in Tel Aviv.
The addicts were split up into 2 groups. One group was given heroin by itself and the other group was given this new cocktail. At 1st we injected the addicts with a maintenance dose of drugs and found there was no increased affect. Then we gave the addicts a large dose. The results were highly favourable.
The symptomology between the 2 groups was striking and very apparent. The group that was given a large dose of heroin by itself would get on the nod (the head leans downward with the chin touching the chest almost as though the person was going to sleep). The group of addicts that was given the new cocktail didn’t get on the nod. Their heads would stay upright and their eyes would stay open.
Most of the addicts preferred a large does of the new cocktail over a large does of heroin by itself.
Because the new drug cocktail only comes into effect when the dose was relatively high only the most severely pained pain patients were in line the new the new cocktail. In a medical sense the results were also highly favourable. The new cocktail causes less reduction in blood pressure, less nausea, less itching, more euphoria and more analgesia than just morphine by itself.
We gave this new cocktail to some of our wounded soldiers and some terminally ill cancer patients with great results.
The pharmokinetics are simple but sound.
The morphine metabolite stimulates the Mu opiate receptor. The oxycodone stimulates the Kappa opiate receptor. The stimulation of the two receptors at the same time causes an interaction.
In 2009 we tested this new cocktail on some opiate addicts at a heroin maintenance clinic in Tel Aviv.
The addicts were split up into 2 groups. One group was given heroin by itself and the other group was given this new cocktail. At 1st we injected the addicts with a maintenance dose of drugs and found there was no increased affect. Then we gave the addicts a large dose. The results were highly favourable.
The symptomology between the 2 groups was striking and very apparent. The group that was given a large dose of heroin by itself would get on the nod (the head leans downward with the chin touching the chest almost as though the person was going to sleep). The group of addicts that was given the new cocktail didn’t get on the nod. Their heads would stay upright and their eyes would stay open.
Most of the addicts preferred a large does of the new cocktail over a large does of heroin by itself.
Because the new drug cocktail only comes into effect when the dose was relatively high only the most severely pained pain patients were in line the new the new cocktail. In a medical sense the results were also highly favourable. The new cocktail causes less reduction in blood pressure, less nausea, less itching, more euphoria and more analgesia than just morphine by itself.
We gave this new cocktail to some of our wounded soldiers and some terminally ill cancer patients with great results.